Certain Sodium and Potassium Phosphate Salts from China (P)

Information collections for import injury investigations (producers, importers, purchasers, and foreign producer questionnaires and institution notices for 5-year reviews)

Certain Phosphate Salts (prelim) US instructions

Certain Sodium and Potassium Phosphate Salts from China (P)

OMB: 3117-0016

Document [pdf]
Download: pdf | pdf
INSTRUCTION BOOKLET
GENERAL INFORMATION, INSTRUCTIONS, AND
DEFINITIONS FOR COMMISSION QUESTIONNAIRES

Certain Sodium and Potassium Phosphate Salts from China
Investigation Nos. 701-TA-473 and 731-TA-1173 (Preliminary)

Further information.--If you have any questions concerning the enclosed
questionnaire(s) or other matters related to these investigations, you may contact
the following members of the Commission=s staff (Fax 202-205-3205):
Jennifer Merrill, investigator (202-205-3188; E-mail Jennifer.Merrill@USITC.GOV)
regarding general questions and trade and related information;
Justin Jee, auditor (202-205-3186; E-mail Justin.Jee@USITC.GOV)
regarding financial information; and
Craig Thomsen, economist (202-205-3226; E-mail Craig.Thomsen@USITC.GOV)
regarding pricing, market, and related information.

GENERAL INFORMATION
Background.--These investigations were instituted in response to a petition filed on September 24,
2009, by ICL Performance Products, LP (St. Louis, MO) and Prayon, Inc. (Augusta, GA).
Countervailing and/or antidumping duties may be assessed on the subject imports as a result of
these investigations if the Commission makes an affirmative determination of injury, threat, or
material retardation, and if the U.S. Department of Commerce makes an affirmative determination
of subsidization and/or dumping.
Questionnaires and other information pertinent to these investigations are available at
http://www.usitc.gov/trade_remedy/731_ad_701_cvd/investigations/active/index.htm. Address
all correspondence to the United States International Trade Commission, Washington, DC 20436.
Hearing-impaired individuals can obtain information regarding this investigation via the
Commission=s TDD terminal (202-205-1810).
Due date of questionnaire(s).--Return the completed questionnaire(s) to the United States
International Trade Commission by no later than October 8, 2009. Although the enclosed
postpaid envelope may be used to return the completed questionnaire, use of an overnight mail
service may be necessary to ensure that your response actually reaches the Commission by
October 8, 2009. If you do not use the enclosed envelope, please make sure the completed
questionnaire is sent to the attention of Jennifer Merrill. Return only one copy of the completed
questionnaire(s), but please keep a copy for your records so that you can refer to it if the
Commission staff contacts you with any questions during the course of the investigations.
Service of questionnaire response(s).--In the event that your firm is a party to these investigations,
you are required to serve a copy of the questionnaire(s), once completed, on parties to the
proceeding that are subject to administrative protective order (see 19 CFR ' 207.7). A list of such
parties is maintained by the Commission=s Secretary and may be obtained by calling
202-205-1803. A certificate of service must accompany the copy of the completed questionnaire(s)
you submit (see 19 CFR ' 207.7).
Confidentiality.--The commercial and financial data furnished in response to the enclosed
questionnaire(s) that reveal the individual operations of your firm will be treated as confidential by
the Commission to the extent that such data are not otherwise available to the public and will not
be disclosed except as may be required by law (see 19 U.S.C. ' 1677f). Such confidential
information will not be published in a manner that will reveal the individual operations of your
firm; however, nonnumerical characterizations of numerical business proprietary information
(such as discussion of trends) will be treated as confidential business information only at the
request of the submitter for good cause shown.
Verification.--The information submitted in the enclosed questionnaire(s) is subject to audit
and verification by the Commission. To facilitate possible verification of data, please keep
all your workpapers and supporting documents used in the preparation of the questionnaire
response(s).

2

GENERAL INFORMATION--Continued
Release of information.--The information provided by your firm in response to the
questionnaire(s), as well as any other business proprietary information submitted by your firm to
the Commission in connection with the investigations, may become subject to, and released under,
the administrative protective order provisions of the Tariff Act of 1930 (19 U.S.C. ' 1677f) and
section 207.7 of the Commission=s Rules of Practice and Procedure (19 CFR ' 207.7). This means
that certain lawyers and other authorized individuals may temporarily be given access to the
information for use in connection with this investigation or other import-injury investigations
conducted by the Commission on the same or similar merchandise; those individuals would be
subject to severe penalties if the information were divulged to unauthorized individuals. In
addition, if your firm is a U.S. producer, the information you provide on your production and
imports of certain sodium and potassium phosphate salts and your responses to the questions in
Part I of the producer questionnaire will be provided to the U.S. Department of Commerce, upon
its request, for use in connection with (and only in connection with) its requirement pursuant to
sections 702(c)(4) and 732(c)(4) of the Act (19 U.S.C. ' ' 1671a(c)(4)/1673a(c)(4)) to make a
determination concerning the extent of industry support for the petition requesting these
investigations. Any information provided to Commerce will be transmitted under the
confidentiality and release guidelines set forth above. Your response to these questions constitutes
your consent that such information be provided to Commerce under the conditions described
above.

INSTRUCTIONS
Answer all questions.--Do not leave any question or section blank unless a questionnaire
expressly directs you to skip over certain questions or sections. If the answer to any question is
Anone,@ write Anone.@ If information is not readily available from your records in exactly the
form requested, furnish carefully prepared estimates--designated as such by the letter
AE@--and explain the basis of your estimates. Answers to questions and any necessary
comments or explanations should be supplied in the space provided or on separate sheets attached
to the appropriate page of the questionnaire(s). If your firm is completing more than one
questionnaire in connection with this investigation (i.e., a producer, importer, and/or purchaser
questionnaire), you need not respond to duplicated questions in the questionnaires.
Consolidate all U.S. establishments.--Report the requested data for your establishment(s) located
in the United States. Firms operating more than one establishment should combine the data
for all establishments into a single report.
Filing instructions.—Questionnaires may be filed either in paper form or electronically.

3

INSTRUCTIONS--Continued
OPTIONS FOR FILING IN PAPER FORM
• Overnight mail service.—Mail to the following address:
United States International Trade Commission
Office of Investigations, Room 615
500 E Street SW
Washington, DC 20024
• Fax.—Fax to 202.205.3205.
• U.S. mail.—Mail to the address above, but use zip code 20436. This option is not recommended.
U.S. mail sent to government offices undergoes additional processing to screen for hazardous
materials; this additional processing results in substantial delays in delivery.
OPTIONS FOR FILING ELECTRONICALLY
This questionnaire is available as a “fillable” form in MS Word format on the
Commission’s website at http://www.usitc.gov/trade_remedy/731_ad_701_cvd/
investigations/active/index.htm. Please do not attempt to modify the format or
permissions of the questionnaire document. You may complete the questionnaire
electronically, print it out, and submit it in paper form as described above, or you
may submit it electronically through one of the following means:
• Compact disc (CD).—Copy your questionnaire onto a CD, include a signed certification page
(page 1) (either in paper form or scanned PDF copied onto CD), and mail to the address above. It
is strongly recommended that you use an overnight mail service. U.S. mail sent to government
offices undergoes additional processing which not only results in substantial delays in delivery but
may also damage CDs.
• E-mail.—E-mail your questionnaire to the investigator identified on page 1 of the Instruction
Booklet; include a scanned PDF of the signed certification page (page 1). Type the following in
the e-mail subject line: BPI Questionnaire, INV. NOS. 701-TA-473 and 731-TA-1173. Please
note that submitting your questionnaire by e-mail may subject your firm’s business proprietary
information to transmission over an unsecure environment and to possible disclosure. If you
choose this option, the Commission warns you that any risk involving possible disclosure of such
information is assumed by the submitter and not by the Commission.
Note: If you are a party to the investigations, and service of the questionnaire is required,
such service should be made in paper form.

4

DEFINITIONS
Certain Sodium and Potassium Phosphate Salts (“Certain Phosphate
Salts”). -- The phosphate salts covered by these investigations include Sodium
Tripolyphosphate (STPP), whether anhydrous or in solution, anhydrous
Monopotassium Phosphate (MKP), anhydrous Dipotassium Phosphate (DKP), and
Tetrapotassium Pyrophosphate (TKPP), whether anhydrous or in solution
(collectively “phosphate salts”).
DKP, also known as Dipotassium salt, Dipotassium hydrogen
orthophosphate or Potassium phosphate, dibasic, has a chemical
formula of K2HPO4. The Chemical Abstracts Service registry
number for DKP is 7758-11-4. DKP is typically 17.8% phosphorus,
44.8% potassium and 40% P2O5 content. DKP is classified under
subheading 2835.24.0000, HTSUS.
MKP, also known as Potassium dihydrogen phosphate, KDP, or
Monobasic potassium phosphate, is a potassium salt with the
formula KH2PO4. The Chemical Abstracts Service registry number
for MKP is 7778-77-0. MKP is typically 22.7% phosphorus, 28.7%
potassium and 52% P2O5. MKP is classified under subheading
2835.24.0000, HTSUS.
STPP, also known as Sodium triphosphate, Tripoly or Pentasodium
triphosphate, is a sodium polyphosphate with the formula Na5O10P3.
The Chemical Abstracts Service registry number for STPP is
7758-29-4. STPP is typically 25% phosphorus, 31% sodium and
57% diphosphorus pentoxide (P2O5). STPP is classified under
subheading 2835.31.0000, HTSUS.
TKPP, also known as normal potassium pyrophosphate,
Diphosphoric acid or Tetrapotassium salt, is a potassium salt with
the formula K4P2O7. The Chemical Abstracts Service registry
number for TKPP is 7320-34-5. TKPP is typically 18.7%
phosphorus and 47.3% potassium. It is generally greater than or
equal to 43.0% P2O5 content. TKPP is classified under subheading
2835.39.1000, HTSUS.
The products covered by these investigations include the foregoing
phosphate salts in all grades, whether food grade or technical grade. The
product covered by these investigations includes anhydrous MKP and DKP
without regard to the physical form, whether crushed, granule, powder or
fines. Also covered are all forms of STPP and TKPP, whether crushed,
granule, powder, fines or solution.
For purposes of the investigations, the narrative description is dispositive,
5

not the tariff heading, Chemical Abstracts Service registry number or
Chemical Abstracts Service name, or the specific percentage chemical
composition identified above.
Firm.--An individual proprietorship, partnership, joint venture, association, corporation
(including any subsidiary corporation), business trust, cooperative, trustee in bankruptcy, or
receiver under decree of any court.
Related firm.--A firm that your firm solely or jointly owned, managed, or otherwise controlled; a
firm that solely or jointly owned, managed, or otherwise controlled your firm; and/or a firm that
was solely or jointly owned, managed, or otherwise controlled by a firm that also solely or jointly
owned, managed, or otherwise controlled your firm.
Establishment.--Each facility of a firm in the United States involved in the production,
importation, and/or purchase of certain phosphate salts (as defined above), including auxiliary
facilities operated in conjunction with (whether or not physically separate from) such facilities.
United States.--For purposes of these investigations, the 50 States, Puerto Rico, the U.S. Virgin
Islands, and the District of Columbia.
Importer.--Any person or firm engaged, either directly or through a parent company or subsidiary,
in importing certain phosphate salts (as defined above) into the United States from a foreign
manufacturer or through its selling agent.
Imports.--Those products identified for Customs purposes as imports for consumption for which
your firm was the importer of record (i.e., was responsible for paying any import duty) or
consignee (i.e., to which the merchandise was first delivered).
Import quantities.--Quantities reported should be net of returns.
Import values.--Values reported should be landed, duty-paid values at the U.S. port of
entry, including ocean freight and insurance costs, brokerage charges, and import duties
(i.e., all charges except inland freight in the United States).
Purchaser.--Any person or firm engaged, either directly or through a parent company or
subsidiary, in purchasing certain phosphate salts (as defined above) from another firm that
produces, imports, or otherwise distributes certain phosphate salts. A retail firm that is the
importer of record may be considered a purchaser.

6

DEFINITIONS--Continued
Purchases.--Purchases from all sources, NOT including direct imports from foreign producers
(which should be reported in an importer questionnaire).
Purchase quantities.--Quantities reported should be net of returns.
Purchase values.--Values reported should be net values (i.e., gross purchase values less all
discounts, allowances, rebates, and the value of returned goods), delivered to your U.S.
receiving point.
Shipments.--Shipments of products produced in or imported by your U.S. establishment(s).
Include shipments to the contracting firm of product produced by your firm under a toll agreement.
Shipment quantities.--Quantities reported should be net of returns.
Shipment values.--Values reported should be net values (i.e., gross sales values less all
discounts, allowances, rebates, prepaid freight, and the value of returned goods), f.o.b.
your U.S. point of shipment. The value of domestic shipments to the contracting firm
under a toll agreement is the conversion fee (including profit).
Types of shipments:
U.S. shipments.--Commercial shipments, internal consumption, and transfers to related
firms within the United States.
Commercial shipments.--Shipments, other than internal consumption and transfers
to related firms, within the United States.
Internal consumption.--Product consumed internally by your firm.
Transfers to related firms.--Shipments made to related domestic firms.
Export shipments.--Shipments to destinations outside the United States, including
shipments to related firms.
Inventories.--Finished goods inventory, not raw materials or work-in-progress.
The following definitions apply only to the PRODUCER QUESTIONNAIRE.
Average production capacity.--The level of production that your establishment(s) could
reasonably have expected to attain during the specified periods. Assume normal operating
conditions (i.e., using equipment and machinery in place and ready to operate; normal operating
levels (hours per week/weeks per year) and time for downtime, maintenance, repair, and cleanup;
and a typical or representative product mix).
7

DEFINITIONS--Continued
Toll agreement.--Agreement between two firms whereby the first firm furnishes the raw materials
and the second firm uses the raw materials to produce a product that it then returns to the first firm
with a charge for processing costs, overhead, etc.
Production.--All production in your U.S. establishment(s), including production consumed
internally within your firm and production for another firm under a toll agreement.
PRWs.--Production and related workers, including working supervisors and all nonsupervisory
workers (including group leaders and trainees) engaged in fabricating, processing, assembling,
inspecting, receiving, storage, handling, packing, warehousing, shipping, trucking, hauling,
maintenance, repair, janitorial and guard services, product development, auxiliary production for
plant=s own use (e.g., power plant), recordkeeping, and other services closely associated with the
above production operations.
Average number employed.--Add the number of employees, both full-time and part-time, for the
12 pay periods ending closest to the 15th of the month and divide that total by 12. For the
January-June periods, calculate similarly and divide by 6.
Hours worked.--Include time paid for sick leave, holidays, and vacation time. Include overtime
hours actually worked; do not convert overtime pay to its equivalent in straight-time hours.
Wages paid.--Total wages paid before deductions of any kind (e.g., withholding taxes, old-age and
unemployment insurance, group insurance, union dues, bonds, etc.). Include wages paid directly
by your firm for overtime, holidays, vacations, and sick leave.
Fiscal year.--The 12-month period between settlement of your firm=s financial accounts.
Purchases other than direct imports.--Purchases from U.S. producers, U.S. importers, and other
U.S. sources.

8


File Typeapplication/pdf
File TitleMicrosoft Word - U.S. Instructions.doc
Authorjennifer.merrill
File Modified2009-09-28
File Created2009-09-28

© 2024 OMB.report | Privacy Policy